Harvard Neuroscientist Bradley Hyman Joins Toffler Trust Advisory Board

As the John B. Penney Professor of Neurology and director at the Massachusetts General Institute for Neurodegenerative Disease, Hyman brings over thirty years of expertise to the role. His career has been defined by mapping the biological mechanisms of Alzheimer’s and cultivating academic talent. Deborah Westphal, CEO of the Trust, noted that Hyman’s background is critical for identifying research opportunities that often fall outside the scope of traditional funding mechanisms.

Hyman’s involvement arrives during a period of rapid technological shift, with fields like computational biology, artificial intelligence, and biomarker discovery fundamentally altering neuroscientific inquiry. The Trust aims to leverage his guidance to bridge gaps between disciplines and institutions. Hyman emphasized that the organization’s model aligns with the forward-thinking philosophy of its namesakes, Alvin and Heidi Toffler, by prioritizing agility in supporting ambitious, early-stage scientific ideas.